Page 4 - Celularity Inc News Today

Celularity (NASDAQ:CELU – Get Free Report) will be issuing its quarterly earnings data on Friday, November 24th. Celularity Price Performance Shares of NASDAQ CELU opened at $0.21 on Thursday. Celularity has a 12-month low of $0.19 and a 12-month high of $1.85. The stock has a 50 day simple moving average of $0.23 and a […]

MARKET WRAPS Watch For: Durable Goods for October, Weekly Jobless Claims, University of Michigan Final Consumer Survey, EIA Weekly Petroleum Status Report Todays Top Headlines/Must... -November 22, 2023 at 06:16 am EST - MarketScreener

SFDA Classification Establishes Clear Regulatory Pathway for Importation of Celularity’s Commercial Biomaterial Products into the Kingdom of Saudi Arabia FLORHAM PARK, N.J., Oct. 18, 2023 --...

Celularity Inc. (NASDAQ:CELU – Get Free Report) was the target of a large drop in short interest in September. As of September 15th, there was short interest totalling 1,130,000 shares, a drop of 33.5% from the August 31st total of 1,700,000 shares. Based on an average daily volume of 585,600 shares, the days-to-cover ratio is […]

Celularity Inc. (NASDAQ:CELUW – Get Free Report) was the target of a significant growth in short interest in September. As of September 15th, there was short interest totalling 4,700 shares, a growth of 38.2% from the August 31st total of 3,400 shares. Based on an average daily trading volume, of 30,500 shares, the days-to-cover ratio […]

Celularity Inc. (NASDAQ:CELU – Get Free Report) was the recipient of a large decline in short interest in the month of September. As of September 15th, there was short interest totalling 1,130,000 shares, a decline of 33.5% from the August 31st total of 1,700,000 shares. Based on an average trading volume of 585,600 shares, the […]

On September 20, 2023, Elizabeth Czerepak, the Executive Vice President, Chief Business Officer, Principal Accounting Officer and Secretary of Scilex Holding Company , resigned from the Company,...

FLORHAM PARK, N.J., Sept. 07, 2023 (GLOBE NEWSWIRE) -- Celularity Inc. (NASDAQ:CELU) (Celularity), a biotechnology company developing placental-derived off-the-shelf allogeneic cell therapies and advanced biomaterial

For investors seeking potential gains, one effective strategy is to identify stocks that are currently on an upward trajectory. These stocks, which show strong upward movement, often continue their positive trend for

Celularity Inc. (NASDAQ:CELUW – Get Free Report) was the target of a large decline in short interest during the month of August. As of August 15th, there was short interest totalling 3,300 shares, a decline of 5.7% from the July 31st total of 3,500 shares. Based on an average daily volume of 48,200 shares, the […]